Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Xiangjiang Feng"'
Autor:
Yangyang Ding, Keke Huang, Cheng Sun, Zelin Liu, Jinli Zhu, Xunyi Jiao, Ya Liao, Xiangjiang Feng, Jingjing Guo, Chunhua Zhu, Zhimin Zhai, Shudao Xiong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Bruton tyrosine kinase inhibitor (BTKi) combined with rituximab-based chemotherapy benefits diffuse large B-cell lymphoma (DLBCL) patients. However, drug resistance is the major cause of relapse and death of DLBCL. In this study, we conducte
Externí odkaz:
https://doaj.org/article/fa6ebc2c7e2b45e7adecf4864d64bcbb
